UNSPSC 51102907: Amodiaquine/artesunate

This classification is for a combination antimalarial drug. The first component, AMODIAQUINE, has a US FDA Unique Ingredient Identifier of 220236ED28. The second component, ARTESUNATE, has a US FDA Unique Ingredient Identifier of 60W3249T9M.

UNSPSC 51102907 Amodiaquine/artesunate is a Commodity code that shows minimal relevant recent activity in state and local procurement. The code nominally describes a specific antimalarial pharmaceutical combination, yet the recent opportunities posted under this code do not align with procurement of that drug or related antimalarial medications. Instead, the tagged solicitations span emergency medical services software (drug-dosage calculation and EMS protocol integration), general pharmaceutical services for long-term care facilities, pharmacy benefits program administration, and forensic drug reference standards — none of which involve amodiaquine or artesunate procurement.

The mismatch between the code's pharmaceutical specificity and the actual scope of recent solicitations suggests either inconsistent tagging by issuing bodies or a code designation that does not reflect current state and local buying patterns. Issuers in the recent block include Collier County (Florida), Dane County (Wisconsin), and Pinellas County (Florida) at the county level, along with the District of Columbia at the territorial level. Geographic spread across these jurisdictions is too sparse to characterize meaningful concentration. No representative opportunities for amodiaquine or artesunate procurement appear in the recent activity; pursue this code only if your firm directly supplies this pharmaceutical combination and can monitor for mis-tagged RFPs or formal health-department procurement notices outside the standard UNSPSC taxonomy.